Chemical Constituents and Anticancer Activities of Marine-Derived Fungus Trichoderma lixii

Natchanun Sirimangkalakitti,Jianyu Lin,Kazuo Harada,Andi Setiawan,Mitsuhiro Arisawa,Masayoshi Arai
DOI: https://doi.org/10.3390/molecules29092048
IF: 4.6
2024-04-29
Molecules
Abstract:The fungal genus Trichoderma is a rich source of structurally diverse secondary metabolites with remarkable pharmaceutical properties. The chemical constituents and anticancer activities of the marine-derived fungus Trichoderma lixii have never been investigated. In this study, a bioactivity-guided investigation led to the isolation of eleven compounds, including trichodermamide A (1), trichodermamide B (2), aspergillazine A (3), DC1149B (4), ergosterol peroxide (5), cerebrosides D/C (6/7), 5-hydroxy-2,3-dimethyl-7-methoxychromone (8), nafuredin A (9), and harzianumols E/F (10/11). Their structures were identified by using various spectroscopic techniques and compared to those in the literature. Notably, compounds 2 and 5–11 were reported for the first time from this species. Evaluation of the anticancer activities of all isolated compounds was carried out. Compounds 2, 4, and 9 were the most active antiproliferative compounds against three cancer cell lines (human myeloma KMS-11, colorectal HT-29, and pancreas PANC-1). Intriguingly, compound 4 exhibited anti-austerity activity with an IC50 of 22.43 μM against PANC-1 cancer cells under glucose starvation conditions, while compound 2 did not.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The paper aims to study the chemical constituents and anticancer activity of the marine-derived fungus Trichoderma lixii. Specifically: 1. **Chemical Constituents**: Through bioactivity-guided isolation methods, researchers isolated 11 compounds from Trichoderma lixii, including trichodermamide A (1), trichodermamide B (2), aspergillazine A (3), DC1149B (4), ergosterol peroxide (5), cerebrosides D/C (6/7), 5-hydroxy-2,3-dimethyl-7-methoxychromone (8), nafuredin A (9), and harzianumols E/F (10/11). Among these compounds, 2 and 5–11 were isolated from this species for the first time. 2. **Anticancer Activity**: All isolated compounds were evaluated for their anticancer activity. The results showed that compounds 2, 4, and 9 exhibited significant antiproliferative effects against three cancer cell lines (human myeloma KMS-11, colorectal cancer HT-29, and pancreatic cancer PANC-1). Notably, compound 2 showed lower IC50 values (0.7 to 3.6 μM), indicating stronger activity than the positive control cisplatin. 3. **Antiausterity Activity**: Under glucose-starved conditions, compound 4 exhibited selective cytotoxicity against PANC-1 pancreatic cancer cells (IC50 of 22.43 μM), while it did not show selectivity under normal glucose conditions. This suggests that compound 4 is a potential antiausterity drug candidate that can selectively target pancreatic cancer cells adapted to glucose-starved conditions. In summary, this study reveals the importance of Trichoderma lixii as a potential source of anticancer drugs and discovers several new compounds with anticancer and antiausterity activities.